CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


AyurvedaWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug2957 poractant alfa Wiki 0.71
drug2612 Usual Care Wiki 0.32

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D055371 Acute Lung Injury NIH 0.14
D012127 Respiratory Distress Syndrome, Newborn NIH 0.14
D012128 Respiratory Distress Syndrome, Adult NIH 0.12
D013577 Syndrome NIH 0.08

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There are 2 clinical trials

Clinical Trials


1 Ayurveda for Flu-like Illness During the Covid 19 Outbreak: Non Randomised Single-blind Controlled Trial

This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu like illness during the Covid 19 outbreak.

NCT04351542 Flu Like Illness Dietary Supplement: Ayurveda Other: Usual Care

Primary Outcomes

Description: Time to bring down a fever (oral temperature < 37.2 ̊C)

Measure: Time to achieve afebrile

Time: Change from baseline to 3rd and 7th-day

Description: Symptoms diary card completed twice daily from Day 0 to Day 7

Measure: Severity of symptom score

Time: Change from baseline to 3rd and 7th day

Secondary Outcomes

Description: Patient reported improvement using 4 scale; 0-none, 1-weak, 2-medium, 3-strong

Measure: Patient reported improvement

Time: Change from baseline to 3rd and 7th-day

2 Effect of Ayurveda as Prophylaxis for Suspected Covid-19 Patients: Randomised Controlled Trial

Despite worldwide efforts to contain, manage and treat Covid-19, the pandemic is continuing to spread. This calls for an urgent clinically-proven prophylaxis and therapeutic strategy. Recent developments on the use of traditional medicines in Covid-19 management has drawn enough attention to start several research studies. Based on the Indian Traditional Medicine, Ayurveda's community initiatives, preliminary studies, and our experiential knowledge on Covid-19 settings, we propose present study to prevent the development of COVID-19 symptoms in people who live or have come contact with an individual diagnosed with COVID-19.

NCT04395976 Covid-19 Other: Ayurveda

Primary Outcomes

Description: Number of participants with symptomatic, lab-confirmed COVID-19

Measure: Clinical confirmation of Covid-19

Time: From date of enrolment to 14 days


No related HPO nodes (Using clinical trials)